KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Work In Process (2016)

Historic Work In Process for AbbVie (ABBV) over the last 5 years, with Q2 2016 value amounting to $1.1 billion.

  • AbbVie's Work In Process rose 480.86% to $1.1 billion in Q2 2016 from the same period last year, while for Jun 2016 it was $1.1 billion, marking a year-over-year increase of 480.86%. This contributed to the annual value of $1.1 billion for FY2015, which is 7186.01% up from last year.
  • AbbVie's Work In Process amounted to $1.1 billion in Q2 2016, which was up 480.86% from $1.1 billion recorded in Q1 2016.
  • In the past 5 years, AbbVie's Work In Process registered a high of $1.1 billion during Q1 2016, and its lowest value of $262.0 million during Q1 2013.
  • Over the past 5 years, AbbVie's median Work In Process value was $568.0 million (recorded in 2015), while the average stood at $672.0 million.
  • Its Work In Process has fluctuated over the past 5 years, first soared by 12285.12% in 2015, then skyrocketed by 480.86% in 2016.
  • Quarter analysis of 5 years shows AbbVie's Work In Process stood at $286.0 million in 2012, then surged by 41.26% to $404.0 million in 2013, then surged by 55.69% to $629.0 million in 2014, then soared by 71.86% to $1.1 billion in 2015, then decreased by 1.2% to $1.1 billion in 2016.
  • Its Work In Process stands at $1.1 billion for Q2 2016, versus $1.1 billion for Q1 2016 and $1.1 billion for Q4 2015.